Clinical trial
Self-controlled Cohort Study of the Amplification and Selection of Antimicrobial Resistance in the Human Intestine
NCT02058888 is registered in ClinicalTrials.gov with University Hospital Tuebingen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Self-controlled Cohort Study of the Amplification and Selection of Antimicrobial Resistance in the Human Intestine
- Lead sponsor
- University Hospital Tuebingen
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2015
- Completion date
- May 31, 2017
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute leukaemia